HEM Pharma Inc. (KOSDAQ:376270)

HEM Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	13,785	6,274
Short-Term Investments	-	5,000
Cash & Short-Term Investments	13,785	11,274
Cash Growth	22.27%	-
Accounts Receivable	1,655	4,371
Other Receivables	46.01	65.79
Receivables	1,708	4,437
Inventory	1,505	975.27
Prepaid Expenses	1,207	521.28
Other Current Assets	4,430	98.49
Total Current Assets	22,635	17,306
Property, Plant & Equipment	26,116	17,628
Long-Term Investments	573.29	46.75
Goodwill	14.34	-
Other Intangible Assets	1,443	793.74
Other Long-Term Assets	1,052	1,087
Total Assets	51,834	36,862
Accounts Payable	1,536	1,125
Accrued Expenses	891.97	576.49
Short-Term Debt	13,448	6,000
Current Portion of Long-Term Debt	166.56	166.56
Current Portion of Leases	444.19	316.2
Current Income Taxes Payable	3.59	-
Other Current Liabilities	23,996	892.18
Total Current Liabilities	40,486	9,077
Long-Term Debt	3,566	305.36
Long-Term Leases	1,630	1,033
Pension & Post-Retirement Benefits	614.23	68.25
Long-Term Deferred Tax Liabilities	68.04	-
Other Long-Term Liabilities	254.83	260.76
Total Liabilities	46,619	10,744
Common Stock	3,579	3,481
Additional Paid-In Capital	69,839	65,911
Retained Earnings	-75,874	-51,864
Comprehensive Income & Other	7,442	8,590
Total Common Equity	4,986	26,118
Minority Interest	228.45	-
Shareholders' Equity	5,215	26,118
Total Liabilities & Equity	51,834	36,862
Total Debt	19,255	7,821
Net Cash (Debt)	-5,470	3,453
Net Cash Per Share	-777.56	543.32
Filing Date Shares Outstanding	7.1	6.95
Total Common Shares Outstanding	7.1	6.95
Working Capital	-17,851	8,229
Book Value Per Share	702.18	3756.88
Tangible Book Value	3,529	25,324
Tangible Book Value Per Share	496.92	3642.70
Land	7,213	6,936
Buildings	5,939	3,510
Machinery	10,137	8,636
Construction In Progress	2,615	1,852

Source: S&P Global Market Intelligence. Standard template. Financial Sources.